Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 20 | 16,000 | 0 | 0 |
| Gross Profit | N/A | 20 | 16,000 | N/A | N/A |
| Operating Expenses | 3,602 | 2,565 | 2,778 | 2,119 | 5,919 |
| Operating Income | -3,602 | -2,545 | 13,222 | -2,119 | -5,919 |
| Other Income | 189 | 323 | 231 | -60 | 156 |
| Pre-tax Income | -3,413 | -2,222 | 13,453 | -2,178 | -5,763 |
| Net Income Continuous | -3,413 | -2,222 | 13,453 | -2,269 | -5,763 |
| Net Income | $-3,413 | $-2,222 | $13,453 | $-2,269 | $-5,763 |
| EPS Basic Total Ops | -0.81 | -0.53 | 4.67 | -0.80 | -7.30 |
| EPS Basic Continuous Ops | -0.81 | -0.53 | 4.67 | 0.20 | -7.29 |
| EPS Diluted Total Ops | -0.81 | -0.53 | 3.46 | -0.80 | -7.30 |
| EPS Diluted Continuous Ops | -0.81 | -0.53 | 3.46 | 0.20 | -7.29 |
| EPS Diluted Before Non-Recurring Items | -0.81 | -0.53 | 3.42 | N/A | N/A |
| EBITDA(a) | $-3,496 | $-2,539 | $13,227 | $-2,111 | $-5,907 |